These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Regulation of chemokine production in response to pro-inflammatory cytokines in first trimester decidual cells. Huang SJ; Schatz F; Masch R; Rahman M; Buchwalder L; Niven-Fairchild T; Tang C; Abrahams VM; Krikun G; Lockwood CJ J Reprod Immunol; 2006 Dec; 72(1-2):60-73. PubMed ID: 16806486 [TBL] [Abstract][Full Text] [Related]
12. Glatiramer acetate and the glatiramoid class of immunomodulator drugs in multiple sclerosis: an update. Johnson KP Expert Opin Drug Metab Toxicol; 2010 May; 6(5):643-60. PubMed ID: 20397968 [TBL] [Abstract][Full Text] [Related]
13. Glatiramer acetate (GA) prevents TNF-α-induced monocyte adhesion to primary endothelial cells through interfering with the NF-κB pathway. Wei G; Zhang X; Su Z; Li X Biochem Biophys Res Commun; 2015 Jan; 457(1):101-5. PubMed ID: 25529444 [TBL] [Abstract][Full Text] [Related]
14. C-reactive protein induces pro- and anti-inflammatory effects, including activation of the liver X receptor alpha, on human monocytes. Hanriot D; Bello G; Ropars A; Seguin-Devaux C; Poitevin G; Grosjean S; Latger-Cannard V; Devaux Y; Zannad F; Regnault V; Lacolley P; Mertes PM; Hess K; Longrois D Thromb Haemost; 2008 Mar; 99(3):558-69. PubMed ID: 18327405 [TBL] [Abstract][Full Text] [Related]
15. Monocytes P2X7 purinergic receptor is modulated by glatiramer acetate in multiple sclerosis. Caragnano M; Tortorella P; Bergami A; Ruggieri M; Livrea P; Specchio LM; Martino G; Trojano M; Furlan R; Avolio C J Neuroimmunol; 2012 Apr; 245(1-2):93-7. PubMed ID: 22370183 [TBL] [Abstract][Full Text] [Related]
16. Multiple sclerosis: expression of CD1a and production of IL-12p70 and IFN-gamma by blood mononuclear cells in patients on combination therapy with IFN-beta and glatiramer acetate compared to monotherapy with IFN-beta. Hussien Y; Sanna A; Söderström M; Link H; Huang YM Mult Scler; 2004 Feb; 10(1):16-25. PubMed ID: 14760948 [TBL] [Abstract][Full Text] [Related]
17. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis. Mitsdoerffer M; Schreiner B; Kieseier BC; Neuhaus O; Dichgans J; Hartung HP; Weller M; Wiendl H J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415 [TBL] [Abstract][Full Text] [Related]
18. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis. Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209 [TBL] [Abstract][Full Text] [Related]
19. Effects of methylprednisolone and glatiramer acetate on nitric oxide formation of cytokine-stimulated cells from the rat oligodendroglial cell line OLN-93. Holzknecht C; Röhl C Neuroimmunomodulation; 2010; 17(1):23-30. PubMed ID: 19816054 [TBL] [Abstract][Full Text] [Related]
20. Induction and antimicrobial activity of platelet basic protein derivatives in human monocytes. Schaffner A; King CC; Schaer D; Guiney DG J Leukoc Biol; 2004 Nov; 76(5):1010-8. PubMed ID: 15316029 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]